Walleye Trading’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.27M Buy
+223,265
New +$5.94M 0.01% 1013
2025
Q4
Sell
-620,407
Closed -$15.6M 4721
2025
Q3
$15.8M Buy
620,407
+93,893
+18% +$2.32M 0.02% 674
2025
Q2
$12.8M Buy
526,514
+166,429
+46% +$3.88M 0.02% 705
2025
Q1
$9.12M Buy
360,085
+177,738
+97% +$4.65M 0.02% 779
2024
Q4
$4.84M Buy
182,347
+118,975
+188% +$3.23M 0.01% 1168
2024
Q3
$1.83M Sell
63,372
-55,753
-47% -$1.63M ﹤0.01% 1731
2024
Q2
$3.33M Sell
119,125
-75,153
-39% -$2.07M 0.01% 1285
2024
Q1
$5.39M Sell
194,278
-61,313
-24% -$1.7M 0.01% 1076
2023
Q4
$7.36M Buy
255,591
+19,383
+8% +$586K 0.02% 968
2023
Q3
$7.84M Buy
236,208
+37,372
+19% +$1.32M 0.02% 815
2023
Q2
$7.29M Sell
198,836
-133,609
-40% -$5.2M 0.02% 727
2023
Q1
$13.6M Sell
332,445
-125,588
-27% -$5.42M 0.03% 509
2022
Q4
$23.5M Sell
458,033
-417,934
-48% -$20M 0.07% 308
2022
Q3
$38.3M Buy
875,967
+251,853
+40% +$12.2M 0.12% 151
2022
Q2
$32.7M Buy
+624,114
New +$31.8M 0.11% 182
2022
Q1
Sell
-321,170
Closed -$16.7M 5782
2021
Q4
$19M Buy
321,170
+151,080
+89% +$7.49M 0.06% 335
2021
Q3
$7.32M Buy
170,090
+101,594
+148% +$4.5M 0.03% 711
2021
Q2
$2.68M Buy
68,496
+39,561
+137% +$1.54M 0.01% 1250
2021
Q1
$1.05M Sell
28,935
-104,366
-78% -$3.71M ﹤0.01% 1873
2020
Q4
$4.91M Buy
+133,301
New +$4.89M 0.02% 746
2020
Q3
Sell
-52,779
Closed -$1.85M 4491
2020
Q2
$1.64M Sell
52,779
-28,561
-35% -$970K 0.01% 1262
2020
Q1
$2.52M Buy
81,340
+2,718
+3% +$92.6K 0.02% 697
2019
Q4
$2.92M Buy
+78,622
New +$2.8M 0.02% 930
2019
Q1
Sell
-17,275
Closed -$692K 4637
2018
Q4
$715K Buy
+17,275
New +$717K 0.01% 2103
2018
Q3
Sell
-26,130
Closed -$1.01M 5471
2018
Q2
$899K Sell
26,130
-63,969
-71% -$2.19M ﹤0.01% 2216
2018
Q1
$3.03M Sell
90,099
-56,566
-39% -$1.94M 0.02% 850
2017
Q4
$5.04K Sell
146,665
-302,504
-67% -$10.3M 0.02% 668
2017
Q3
$15.2K Buy
449,169
+53,081
+13% +$1.71M 0.07% 188
2017
Q2
$12.6K Buy
396,088
+41,783
+12% +$1.32M 0.08% 218
2017
Q1
$11.5K Buy
354,305
+30,942
+10% +$976K 0.08% 183
2016
Q4
$9.96M Buy
+323,363
New +$9.87M 0.07% 196
2016
Q2
Sell
-126,597
Closed -$4.04M 5639
2016
Q1
$3.56M Sell
126,597
-26,948
-18% -$770K 0.03% 533
2015
Q4
$4.7M Buy
+153,545
New +$4.83M 0.05% 388
2015
Q3
Sell
-186,850
Closed -$5.99M 5381
2015
Q2
$5.94M Buy
+186,850
New +$6.09M 0.06% 275
2015
Q1
Sell
-160,078
Closed -$5.09M 4382
2014
Q4
$4.73M Sell
160,078
-5,362
-3% -$154K 0.04% 331
2014
Q3
$4.64M Buy
165,440
+76,195
+85% +$2.14M 0.05% 160
2014
Q2
$2.51K Buy
+89,245
New +$2.54M 0.03% 331
2014
Q1
Sell
-570,407
Closed -$17M 3827
2013
Q4
$16.6M Buy
+570,407
New +$16.6M 0.16% 58

Other funds holding PFE

Walleye Trading's PFE Position: Q1 2026 in Review

Walleye Trading opened a new position in Pfizer (PFE) in Q1 2026: 223,265 shares worth $6.27M. The stake represents 0.01% of the portfolio and ranks #1013 among its holdings. This is a return to the name: Walleye Trading previously reported a position in PFE as recently as Q3 2025.

Walleye Trading first reported a position in PFE in Q4 2013 and has held it in 38 quarters since. The position peaked at $38.3M in Q3 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Walleye Trading held 223,265 shares of Pfizer worth $6.27M as of Q1 2026.
  • Pfizer was a new Walleye Trading position in Q1 2026.
  • Pfizer made up 0.01% of Walleye Trading's portfolio in Q1 2026, its #1013 holding.
  • Walleye Trading first reported a position in Pfizer in Q4 2013 and has held it in 38 quarters since.
  • Walleye Trading's Pfizer position peaked at $38.3M in Q3 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.